The Bcl-2 protein family.
暂无分享,去创建一个
[1] J. Martinou,et al. Bid Induces the Oligomerization and Insertion of Bax into the Outer Mitochondrial Membrane , 2000, Molecular and Cellular Biology.
[2] J. Martinou,et al. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. , 2000, The Biochemical journal.
[3] A. Strasser,et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. , 1999, Science.
[4] S. Korsmeyer,et al. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis , 1999, Nature.
[5] J C Reed,et al. Ion Channel Activity of the BH3 Only Bcl-2 Family Member, BID* , 1999, The Journal of Biological Chemistry.
[6] Masashi Narita,et al. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC , 1999, Nature.
[7] Susan S. Taylor,et al. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. , 1999, Molecular cell.
[8] Jean-Claude Martinou,et al. Bid-induced Conformational Change of Bax Is Responsible for Mitochondrial Cytochrome c Release during Apoptosis , 1999, The Journal of cell biology.
[9] J. Martinou,et al. The Release of Cytochrome c from Mitochondria during Apoptosis of NGF-deprived Sympathetic Neurons Is a Reversible Event , 1999, The Journal of cell biology.
[10] S. Korsmeyer,et al. Solution Structure of the Proapoptotic Molecule BID A Structural Basis for Apoptotic Agonists and Antagonists , 1999, Cell.
[11] Junying Yuan,et al. Solution Structure of BID, an Intracellular Amplifier of Apoptotic Signaling , 1999, Cell.
[12] C. Print,et al. Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] Jean-Claude Martinou,et al. Bax-induced Cytochrome C Release from Mitochondria Is Independent of the Permeability Transition Pore but Highly Dependent on Mg2+ Ions , 1998, The Journal of cell biology.
[14] J C Reed,et al. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. , 1998, Science.
[15] Junying Yuan,et al. Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.
[16] S. Patel,et al. Purification and biochemical properties of soluble recombinant human Bax. , 1998, Protein expression and purification.
[17] J C Reed,et al. Bax directly induces release of cytochrome c from isolated mitochondria. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] G. Kroemer,et al. The Permeability Transition Pore Complex: A Target for Apoptosis Regulation by Caspases and Bcl-2–related Proteins , 1998, The Journal of experimental medicine.
[19] G. Núñez,et al. Mtd, a Novel Bcl-2 Family Member Activates Apoptosis in the Absence of Heterodimerization with Bcl-2 and Bcl-XL * , 1998, The Journal of Biological Chemistry.
[20] C. Borner,et al. Alphaviruses induce apoptosis in Bcl‐2‐overexpressing cells: evidence for a caspase‐mediated, proteolytic inactivation of Bcl‐2 , 1998, The EMBO journal.
[21] M. Skinner,et al. Testicular degeneration in Bclw-deficient mice , 1998, Nature Genetics.
[22] Y. Tsujimoto,et al. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[23] S. Cory,et al. The conserved N‐terminal BH4 domain of Bcl‐2 homologues is essential for inhibition of apoptosis and interaction with CED‐4 , 1998, The EMBO journal.
[24] John Calvin Reed,et al. The Mitochondrial F0F1-ATPase proton pump is required for function of the proapoptotic protein Bax in yeast and mammalian cells. , 1998, Molecular cell.
[25] C. Borner,et al. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c , 1998, Nature.
[26] A. Strasser,et al. Bim: a novel member of the Bcl‐2 family that promotes apoptosis , 1998, The EMBO journal.
[27] E. Cheng,et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. , 1997, Science.
[28] S. Srinivasula,et al. Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.
[29] A. Hsueh,et al. Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[30] S. Korsmeyer,et al. Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction , 1997, Nature Medicine.
[31] L. Peso,et al. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. , 1997, Science.
[32] S. R. Datta,et al. Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.
[33] M. Muda,et al. Bcl-2 Undergoes Phosphorylation by c-Jun N-terminal Kinase/Stress-activated Protein Kinases in the Presence of the Constitutively Active GTP-binding Protein Rac1* , 1997, The Journal of Biological Chemistry.
[34] S. Korsmeyer,et al. BH3 Domain of BAD Is Required for Heterodimerization with BCL-XL and Pro-apoptotic Activity* , 1997, The Journal of Biological Chemistry.
[35] P. Paty,et al. Mitochondrial Proliferation and Paradoxical Membrane Depolarization during Terminal Differentiation and Apoptosis in a Human Colon Carcinoma Cell Line , 1997, The Journal of cell biology.
[36] F Gambale,et al. Inhibition of Bax channel-forming activity by Bcl-2. , 1997, Science.
[37] John Calvin Reed. Double identity for proteins of the Bcl-2 family , 1997, Nature.
[38] J C Reed,et al. Channel formation by antiapoptotic protein Bcl-2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[39] F. Shibasaki,et al. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2 , 1997, Nature.
[40] Y. Hsu,et al. Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[41] S. Fesik,et al. Identification of a novel regulatory domain in Bcl‐xL and Bcl‐2 , 1997, The EMBO journal.
[42] Andy J. Minn,et al. Bcl-xL forms an ion channel in synthetic lipid membranes , 1997, Nature.
[43] Elizabeth Yang,et al. Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.
[44] C. Milliman,et al. BID: a novel BH3 domain-only death agonist. , 1996, Genes & development.
[45] G. Kroemer,et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease , 1996, The Journal of experimental medicine.
[46] S. Korsmeyer,et al. BAX Is Required for Neuronal Death after Trophic Factor Deprivation and during Development , 1996, Neuron.
[47] R. Meadows,et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death , 1996, Nature.
[48] J. Hunter,et al. A Peptide Sequence from Bax That Converts Bcl-2 into an Activator of Apoptosis (*) , 1996, The Journal of Biological Chemistry.
[49] C. Croce,et al. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. , 1996, Cancer research.
[50] E. Cheng,et al. Bax-independent inhibition of apoptosis by Bcl-XL , 1996, Nature.
[51] S. Farrow,et al. New members of the Bcl-2 family and their protein partners. , 1996, Current opinion in genetics & development.
[52] T. Chittenden,et al. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. , 1995, The EMBO journal.
[53] al. et,et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice , 1995, Science.
[54] C. Borner,et al. Dissection of functional domains in Bcl-2 alpha by site-directed mutagenesis. , 1994, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[55] D. Newmeyer,et al. Cell-free apoptosis in Xenopus egg extracts: Inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria , 1994, Cell.
[56] Jean-Claude Martinou,et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia , 1994, Neuron.
[57] S. Krajewski,et al. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. , 1994, Oncogene.
[58] P. Bernardi,et al. Regulation of the permeability transition pore, a voltage-dependent mitochondrial channel inhibited by cyclosporin A. , 1994, Biochimica et biophysica acta.
[59] C. Borner,et al. The protein bcl-2 alpha does not require membrane attachment, but two conserved domains to suppress apoptosis , 1994, The Journal of cell biology.
[60] Z. Oltvai,et al. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax , 1994, Nature.
[61] D. Bredesen,et al. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. , 1993, Science.
[62] S. Korsmeyer,et al. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair , 1993, Cell.
[63] Z. Oltvai,et al. Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.
[64] John Calvin Reed,et al. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. , 1993, Cancer research.
[65] A. Halestrap,et al. Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. , 1990, The Biochemical journal.
[66] Y. Tsujimoto,et al. Involvement of the bcl-2 gene in human follicular lymphoma. , 1985, Science.
[67] D. Green,et al. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD‐specific caspase activation and independently of mitochondrial transmembrane depolarization , 1998, The EMBO journal.
[68] J. Dichgans,et al. Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest. , 1998, British Journal of Cancer.